- Home
- CNMD vs EOS Comparison
CNMD vs EOS Comparison
Compare CNMD & EOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CNMD | EOS |
|---|---|---|
| Founded | 1970 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 985.5M | 1.2B |
| IPO Year | 1995 | 2004 |
Fundamental Metrics
Financial Performance| Metric | CNMD | EOS |
|---|---|---|
| Price | $45.39 | $21.13 |
| Analyst Decision | Hold | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $46.25 | N/A |
| AVG Volume (30 Days) | ★ 736.0K | 95.5K |
| Earning Date | 04-29-2026 | 01-01-0001 |
| Dividend Yield | ★ 1.11% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.51 | N/A |
| Revenue | ★ $1,374,724,000.00 | N/A |
| Revenue This Year | $0.82 | N/A |
| Revenue Next Year | $5.48 | N/A |
| P/E Ratio | $28.81 | ★ N/A |
| Revenue Growth | ★ 5.18 | N/A |
| 52 Week Low | $31.44 | $19.44 |
| 52 Week High | $56.64 | $24.49 |
Technical Indicators
Market Signals| Indicator | CNMD | EOS |
|---|---|---|
| Relative Strength Index (RSI) | 68.17 | 32.44 |
| Support Level | $39.92 | $19.44 |
| Resistance Level | $45.89 | $22.99 |
| Average True Range (ATR) | 2.26 | 0.26 |
| MACD | 0.35 | -0.08 |
| Stochastic Oscillator | 94.03 | 3.66 |
Price Performance
Historical ComparisonAbout CNMD CONMED Corporation
Conmed Corp is a medical technology company that provides devices and equipment for surgical procedures. The company's products are used by surgeons and other healthcare professionals across specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Geographically, the company operates in the United States, Europe, the Middle East & Africa, Asia Pacific, and the Americas, excluding the United States. The majority of revenue is generated from the United States.
About EOS Eaton Vance Enhance Equity Income Fund II
Eaton Vance Enhanced Equity Income Fund II is a diversified, closed-end management investment company. The fund's primary investment objective is to provide current income, with a secondary objective of capital appreciation. Under normal market conditions, the Fund invests at least 80% of its total assets in common stocks. It invests in a portfolio of large and mid-cap securities in sectors such as Information Technology, Consumer Discretionary, Communication Services, Healthcare, Industrials, Consumer Staples, Financials, Materials, and Energy.